about
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach ...
Read More
7.47
-0.91
(-10.86%)
14.6M
XNAS Volume
XNAS 07 May, 2026 2:47 PM (EDT)
Board Meeting
The next board meeting for ImmunityBio Inc is on 12 May 2026 for the purpose of ImmunityBio Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..